-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Among critically ill patients undergoing electroencephalography (EEG) brain monitoring, as many as half of patients have epileptiform periodic and rhythmic brain activity (epilepsy-like activity [EA])
epilepsy
Sahar F.
Sahar F.
This study aims to determine the dose-response relationship between epileptiform activity load and prognosis in acutely ill patients
The research team developed an artificial intelligence algorithm to annotate the 11.
Examples of normal electroencephalogram (EEG), seizures, and periodic seizures
Examples of normal electroencephalogram (EEG), seizures, and periodic seizures
Sahar F.
The peak value of
First 24-hour epileptiform activity (EA) load
First 24-hour epileptiform activity (EA) load
The dose-response relationship between epileptiform activity load and prognosis in subgroup analysis
The dose-response relationship between epileptiform activity load and prognosis in subgroup analysis
The automatic measurement of peak load of epileptiform activities provides a convenient, consistent and quantifiable goal for future multicenter randomized trials to study whether suppression of epileptiform activities can improve results
The automatic measurement of peak load of epileptiform activities provides a convenient, consistent and quantifiable goal for future multicenter randomized trials to study whether suppression of epileptiform activities can improve results
Zafar SF, Rosenthal ES, Jing J, et al.
.
Zafar SF, Rosenthal ES, Jing J, et al Automated Annotation of Epileptiform Burden and Its Association with Outcomes Ann Neurol 2021; 90 (2):.
.
.
300-311 doi: 10.
1002 / ana.
26161
in this message